immune checkpoint inhibitors

Apr 82 min read

Modulating the gut microbiome may improve response to ICB therapy

Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...

Jun 5, 20232 min read

Researchers investigate why some skin cancers stop responding to therapy at end of life

Changes in the order, structure, and number of copies of tumour DNA could be the reason some skin cancers ultimately resist treatment,...

Nov 18, 20221 min read

Nivolumab shows promise in advanced cutaneous squamous cell carcinoma

Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

Jan 14, 20222 min read

Skin reactions may show efficacy of immune checkpoint inhibitors

New findings suggest the development of cutaneous immune-related adverse events (cirAEs) is associated with better treatment efficacy and...

Jan 7, 20222 min read

Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma

Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...

Apr 14, 20211 min read

VIDEO: Study finds 10 skin-related conditions associated with immune checkpoint inhibitors

An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.

Featured Posts